Mike Hooven

President and CEO @Enable Injections, Inc.

Cincinnati, OH, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2010 — Present

President and CEO @Enable Injections, Inc.

View department →

Cincinnati, OH, US

EDUCATION

N/A

University of Michigan College of Engineering

Master's degree, Mechanical Engineering

N/A

University of Michigan College of Literature, Science, and the Arts

Bachelor's degree, Physics

SKILLS

Minimally Invasive ProceduresEntrepreneurshipVenture CapitalBiotechnologyBiomedical EngineeringCardiothoracic SurgerySpineR&DCardiacPatentsHardware DiagnosticsStart-Up VenturesNew Business DevelopmentCommercializationMedicineSurgeonsFdaSurgical InstrumentsStrategic PlanningLeadershipCardiologyManufacturingLife SciencesCross-Functional Team LeadershipMarketing StrategyIso 13485Product DesignProduct LaunchLifesciencesOrthopedicBusiness StrategyMedical DevicesClinical ResearchCapital EquipmentStart-UpsProduct DevelopmentBusiness Planning

ABOUT MIKE HOOVEN

Mike Hooven has over 30 years of experience in the medical device industry in a broad variety of technical and clinical areas. He is currently the Chairman and CEO of Enable Injections, the world’s leading company in high-volume on-body drug delivery. Enable has raised over $300MM in capital and currently has seven partnerships with major and early-stage biotech and pharma companies. Enable’s product, the enFuse, is capable of delivering 5-25 ml of high viscosity drug subcutaneously. The enFuse is FDA approved and being sold by Apellis in the US and Sobi in the ROW. He is the founder of five medical device companies and holds over 100 issued and pending US patents.Mike is the founder, and a Director of AtriCure, Inc.(Nasdaq ATRC). AtriCure is a Medical Device company that manufactures and sells surgical devices to treat the most serious forms of atrial fibrillation. AtriCure has grown rapidly to become the market leader, with over procedures performed. AtriCure completed a successful Initial Public Offering on August 5, 2005, and currently lists on the NASDAQ under the symbol ATRC as a multibillion-dollar company. Mike also is a Director and past Chairman of Ohio Life Sciences, a state-funded organization to accelerate life-science start-up companies in Ohio. Mike was appointed by the Governor to the Third Frontier Advisory Board, a $2.3BB state funded initiative to accelerate high tech job creation in Ohio. Mike also sits on the Commercial Advisory Committee for the University of Cincinnati.Mike previously held positions as the Chairman and CEO of AtriCure, and the Founder and Chairman of Enable Medical, a surgical device manufacturer that was acquired by AtriCure in August of 2005. Mike founded Enable in April of 1994, and prior to that he headed up all internal product development at Ethicon Endo-Surgery from 1988 to 1994. Mike held Engineering positions at Siemens/Pacesetter from 1986 to 1988, and at Cordis Corporation from 1981 to 1986. He earned a BS in Physics and a Master of Science in Mechanical Engineering from the University of Michigan.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.